1. bookAHEAD OF PRINT
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
2501-062X
Pierwsze wydanie
30 Mar 2015
Częstotliwość wydawania
4 razy w roku
Języki
Angielski
Otwarty dostęp

Serum Homocysteine Level and Severity of Coronavirus Disease-2019 (COVID-19)

Data publikacji: 19 Jan 2023
Tom & Zeszyt: AHEAD OF PRINT
Zakres stron: -
Otrzymano: 02 Nov 2022
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
2501-062X
Pierwsze wydanie
30 Mar 2015
Częstotliwość wydawania
4 razy w roku
Języki
Angielski

1. HU Y., SUN J., DAI Z., DENG H., LI X., HUANG Q., et al. Prevalence and severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol. 2020;127:104371.10.1016/j.jcv.2020.104371719543432315817 Search in Google Scholar

2. RUSLIE RH., DARMADI D., SIREGAR GA. Susceptibility of coronavirus disease-19 in pediatric population. Open Access Maced J Med Sci. 2020;8: 363-5.10.3889/oamjms.2020.5240 Search in Google Scholar

3. RAHMAN S., MONTERO MTV., ROWE K., KIRTON R., KUNIK JR F. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol. 2021;14(5):601-21.10.1080/17512433.2021.1902303809516233705239 Search in Google Scholar

4. RUSLIE RH., DARMADI D., SIREGAR GA. Pediatric immunization practice during coronavirus disease-2019 pandemic. Open Access Maced J Med Sci. 2020;8: 258-60.10.3889/oamjms.2020.5125 Search in Google Scholar

5. TONG-MINH K., VAN DER DOES Y., ENGELEN S., DE JONG E., RAMAKERS C., GOMMERS D., et al. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department. BMC Infect Dis. 2022;22(1):165.10.1186/s12879-022-07144-5886027135189826 Search in Google Scholar

6. World Health Organization. WHO coronavirus (COVID-19) dashboard. Available from: covid19.who.int. Accessed 6 October 2022. Search in Google Scholar

7. ZHANG N., XIE T., NING W., HE R., ZHU B., MAO Y. The severity of COVID-19 and its determinants: a systematic review and meta-analysis in China. Sustainability. 2021;13(9):5305.10.3390/su13095305 Search in Google Scholar

8. GHAHRAMANI S., TABRIZI R., LANKARANI KB., KASHANI SMA., REZAEI S., ZEIDI N., et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):30.10.1186/s40001-020-00432-3739694232746929 Search in Google Scholar

9. LAMERSs MM., HAAGMANS BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20(5):270-84.10.1038/s41579-022-00713-035354968 Search in Google Scholar

10. RUSLIE RH., DARMADI D. Coronavirus disease-2019 and mental health. Open Access Maced J Med Sci. 2020;8: 268-71.10.3889/oamjms.2020.5304 Search in Google Scholar

11. PONTI G., MACCAFERRI M., RUINI C., TOMASI A., OZBEN T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389-99.10.1080/10408363.2020.1770685728414732503382 Search in Google Scholar

12. ZENG F., HUANG Y., GUO Y., YIN M., CHEN X., XIAO L., et al. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis. 2020;96:467-74.10.1016/j.ijid.2020.05.055723322632425643 Search in Google Scholar

13. SOLE FD., FARCOMENI S., LOFFREDO L., CARNEVALE R., MENICHELLI D., VICARIO T., et al. Features of severe COVID-19: a systematic review and meta-analysis. Eur J Clin Invest. 2020;50(10):e13378.10.1111/eci.13378743556532860457 Search in Google Scholar

14. AHMEIDI AA., MUSA A., AHMED HS., ELAHMAR AA., GOOTA RB., AHMED IA., et al. Inflammatory markers as predictors of mortality in COVID-19 infection. Afr J Lab Med. 2020;9(1):a1298.10.4102/ajlm.v9i1.1298775652633392056 Search in Google Scholar

15. CARPENE G., NEGRINI D., HENRY BM., MONTAGNANA M., LIPPI G. Homocysteine in coronavirus disease (COVID-19): a systematic literature review. Diagnosis (Berl). 2022;9(3):306-10.10.1515/dx-2022-004235704707 Search in Google Scholar

16. HUANG I., PRANATA R., LIM MA., OEHADIAN A., ALISJAHBANA B. C-reactive protein, procalcitonin, D-dimer, and feritin in severe coronavirus disease-2019: a meta analysis. Ther Adv Respir Dis. 2020;14:1753466620937175.10.1177/1753466620937175733682832615866 Search in Google Scholar

17. KHEDAR RS., GUPTA R., SHARMA KK., MITTAL K., AMBALIYA HC., GUPTA JB., et al. Biomarkers and outcomes in hospitalized covid-19 patients: a prospective registry. medRxiv. 2022;20:22277718. Search in Google Scholar

18. KESKIN A., USTUN GU., ACI R., DURAN U. Homocysteine as a marker for predicting disease severity in patients with COVID-19. Biomark Med. 2022;16(7):559-68.10.2217/bmm-2021-068835343243 Search in Google Scholar

19. PONTI G., PASTORINO L., MANFREDINI M., OZBEN T., OLIVIA G., KALECI S., et al. COVID-19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence. J Clin Lab Anal. 2021;35(7):e23798.10.1002/jcla.23798820995334061414 Search in Google Scholar

20. DARMADI D., PAKPAHAN C., RUSLIE RH., REZANO A. Inflammatory laboratory findings associated with severe illness among hospitalized individuals with COVID-19 in Medan, Indonesia: a cross-sectional study. F1000Res. 2021; 10: 1246.10.12688/f1000research.74758.1 Search in Google Scholar

21. HEIDARI-BENI F., VAHEDIAN-AZIMI A., SHOJAEI S., RAHIMI-BASHAR F., SHARIARY A., JOHNSTON TP., et al. The level of procalcitonin in severe COVID-19 patients: a systematic review and meta-analysis. Adv Exp Med Biol. 2021;1321:277-86.10.1007/978-3-030-59261-5_2533656733 Search in Google Scholar

22. HEER RS., MANDAL AKJ., SZAWARSKI P., MISSOURIS CG. Procalcitonin is a biomarker for disease severity rather than bacterial co-infection in COVID-19. Eur J Emerg Med. 2022;29(4):315.10.1097/MEJ.0000000000000882924155434560701 Search in Google Scholar

Polecane artykuły z Trend MD

Zaplanuj zdalną konferencję ze Sciendo